BMB Reports : eISSN 1976-670X

Cited by CrossRef (21)

  1. Cera Nieto, Bettina Miller, Nathaniel Alzofon, Tugy Chimed, Jack Himes, Molishree Joshi, Karina Gomez, Farshad N Chowdhury, Phuong N Le, Alice Weaver, Hilary Somerset, J Jason Morton, Jing H Wang, Xiao-Jing Wang, Dexiang Gao, Kirk Hansen, Stephen B Keysar, Antonio Jimeno. The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma. 2023;115:1392
    https://doi.org/10.1093/jnci/djad126
  2. Anna Dąbrowska, Magdalena Grubba, Amar Balihodzic, Olga Szot, Bartosz Kamil Sobocki, Adrian Perdyan. The Role of Regulatory T Cells in Cancer Treatment Resistance. IJMS 2023;24:14114
    https://doi.org/10.3390/ijms241814114
  3. Kaizhen Wang, Xiangyu Zhang, Yao Cheng, Zhihao Qi, Ke Ye, Kuojun Zhang, Sheng Jiang, Yi Liu, Yibei Xiao, Tianyu Wang. Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy. J. Med. Chem. 2023;66:16807
    https://doi.org/10.1021/acs.jmedchem.3c01534
  4. Mamatha Garige, Susmita Ghosh, Alexis Norris, Guangyuan Li, Sarah Poncet, Chao-Kai Chou, Wells W. Wu, Rong-Fong Shen, Carole Sourbier. PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.858379
  5. Elena Levantini, Giorgia Maroni, Marzia Del Re, Daniel G. Tenen. EGFR signaling pathway as therapeutic target in human cancers. Seminars in Cancer Biology 2022;85:253
    https://doi.org/10.1016/j.semcancer.2022.04.002
  6. Je-Jung Lee, So Young Kim, Songhee H. Kim, Seoyeon Choi, Bin Lee, Jeon-Soo Shin. STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells. Cell Death Dis 2022;13
    https://doi.org/10.1038/s41419-022-05217-6
  7. Yunxia Ma, Rumyana Marinkova, Miljana Nenkov, Lai Jin, Otmar Huber, Jürgen Sonnemann, Natália Peca, Nikolaus Gaßler, Yuan Chen. Tumor-Intrinsic PD-L1 Exerts an Oncogenic Function through the Activation of the Wnt/β-Catenin Pathway in Human Non-Small Cell Lung Cancer. IJMS 2022;23:11031
    https://doi.org/10.3390/ijms231911031
  8. Shi-Ming Tu, Anup K. Trikannad, Sruthi Vellanki, Munawwar Hussain, Nazish Malik, Sunny R. Singh, Anusha Jillella, Sri Obulareddy, Sindhu Malapati, Sajjad A. Bhatti, Konstantinos Arnaoutakis, Omar T. Atiq. Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care. Cancers 2024;16:1151
    https://doi.org/10.3390/cancers16061151
  9. Chi-Hyun Ahn, Kyu-Young Oh, Bohwan Jin, Won Woo Lee, Jihoon Kim, Hyun-Ji Kim, Dong-Guk Park, Neeti Swarup, Kunal Chawla, Mi Heon Ryu, Uk-Kyu Kim, Su-Jung Choi, Hye-Jung Yoon, Seong-Doo Hong, Ji-Ae Shin, Sung-Dae Cho. Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3β-dependent Snail degradation. Cell Oncol. 2023;46:267
    https://doi.org/10.1007/s13402-022-00748-8
  10. Kyu‐Young Oh, Seong‐Doo Hong, Hye‐Jung Yoon. Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade. J Oral Pathology Medicine 2024;53:217
    https://doi.org/10.1111/jop.13525
  11. Lili Song, Shikai Liu, Sufen Zhao. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway. Bioengineered 2022;13:11240
    https://doi.org/10.1080/21655979.2022.2064205
  12. Sena Zeynep Usta, Toshihiro Uchihashi, Shingo Kodama, Kyoko Kurioka, Toshihiro Inubushi, Takuya Shimooka, Akinari Sugauchi, Soju Seki, Susumu Tanaka. Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma. IJMS 2023;24:17282
    https://doi.org/10.3390/ijms242417282
  13. Myong Hak Ri, Juan Ma, Xuejun Jin. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. Journal of Ethnopharmacology 2021;281:114370
    https://doi.org/10.1016/j.jep.2021.114370
  14. Guangyuan Li, Susmita Ghosh, JuMe Park, Hyunsu Shin, Mamatha Garige, Gregory Reaman, Carole Sourbier. A mouse pancreatic organoid model to compare PD-L1 blocking antibodies. mAbs 2022;14
    https://doi.org/10.1080/19420862.2022.2139886
  15. Mojdeh Soltani, Mustafa Ghanadian, Behrooz Ghezelbash, Abolfazl Shokouhi, Andrey A. Zamyatnin, Alexandr V. Bazhin, Mazdak Ganjalikhani-Hakemi. PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia. BMC Cancer 2023;23
    https://doi.org/10.1186/s12885-023-10947-7
  16. Ahmed Halima, Winston Vuong, Timothy A. Chan. Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy. 2022;132
    https://doi.org/10.1172/JCI154945
  17. Jihyun Moon, Yoo Min Oh, Sang-Jun Ha. Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications. BMB Rep 2021;54:403
    https://doi.org/10.5483/BMBRep.2021.54.8.054
  18. Swarnendu Bag, Janina Oetjen, Soni Shaikh, Amrita Chaudhary, Pattatheyil Arun, Geetashree Mukherjee. Impact of spatial metabolomics on immune-microenvironment in oral cancer prognosis: a clinical report. Mol Cell Biochem 2024;479:41
    https://doi.org/10.1007/s11010-023-04713-3
  19. Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, Arielle De La Cruz, Andrew George, Taylor E. Arnoff, Wafik S. El-Deiry. The role of p53 in anti-tumor immunity and response to immunotherapy. Front. Mol. Biosci. 2023;10
    https://doi.org/10.3389/fmolb.2023.1148389
  20. Nofar Erlichman, Tsipi Meshel, Tamir Baram, Alaa Abu Raiya, Tamar Horvitz, Hagar Ben-Yaakov, Adit Ben-Baruch. The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1. Cells 2023;12:2338
    https://doi.org/10.3390/cells12192338
  21. Abishek Chakkaravarthi Moorthy, Vindu Srivastava. Systematic review on PDL-1 exression in human cancer. IJPO 2022;9:298
    https://doi.org/10.18231/j.ijpo.2022.072